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Abstract. Modern clinical observations focused on the increasing complications at the open 
mandible fracture, which indicated about severe immune suppression in patients with this 
pathology. For estimation cellular immunity in a peripheral blood there were examined 25 patients 
in basic group (15 men, 10 women) with mandible fracture, complicated with abscess of a bone 
wound; control group included 20 practically healthy persons (10 men and 10 women). To assess 
cellular immunity in the peripheral blood were determined: absolute number of leukocytes, relative 
amount of lymphocytes; phagocytic activity. Determination relative number of T–lymphocytes 
(phenotype CD2+, СD3+) and B – lymphocytes (phenotype СD22+) was performed by method of 
immunofluorescence with monoclonal antibodies. In a case of mandible fracture, complicated with 
abscess of bone wound and leukocytosis, in the patients were reduced parameters of cellular 
immunity: on 40.3% – phagocytic index, on 47.7% – phagocytic number, on 43.9% – content of 
CD2+– and CD3+– lymphocytes. Content of null cells was increased on 76.8 %.    
On the 7th day of postoperative treatment in patients from basic group was decreased level of 
leukocytes on 16.5%, increased level of monocytes on 28.6%, and lymphocytes – on 13.4%, which 
indicated about decreasing of inflammatory process and active current of reparative process. After 
14 day of clinical observations, leukocytes and lymphocytes were in the normal values. It was noted 
increasing indicators of phagocytic activity, but number of T–lymphocytes was reduced. Content of 
null cells did not have significant difference from it initial level, which was before treatment. 
Indicators of cellular immunity demonstrated incompleteness of inflammatory process and 
immunosuppression activity, which was carried out two weeks after traditional treatment of the 
bone wound suppuration in a case of mandible fracture. This requires development of a new 
approach of pathogenetic therapy. 
Introduction 
The numerous studies were focused on the treatment of mandible fracture. On the one hand, 
there are numerous innovative methods of diagnostics and treatment of the given pathology. On the 
other hand, at the patients was shown a lot of complications, especially at the open mandible 
fractures [1, 2, 3]. Frequency of the purulent inflammatory complications of mandible fractures 
ranges from 4.4 % to 40 % cases [4, 5, 6].   
According to the literature review, attention of researchers was focused on the fact, that 
purulent-inflammatory diseases of maxillofacial region were associated with changes of the 
immune parameters, having a significant diagnostic value [7, 8, 9, 10, 11].  
The key problem should be focused on the adequate clinical assessment of patient in the 
dynamics of treatment, such as changes of the cellular immunity parameters in a peripheral blood. 
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Material and Methods 
In the basic group – 25 patients with mandibular fracture (15 men, 10 women) undergone 
medical examination. Control group included 20 absolutely healthy persons (10 men and  
10 women). In both groups amount of leukocytes and indicators of cellular immunity in dynamics 
were research. Indicators of peripheral blood in patients with mandible fracture had been taken 
three times: at the hospitalization, after 7 and 14 days of treatment.   
In a peripheral blood stream indicators of cellular immunity were determined: absolute 
number of leukocytes, amount of lymphocytes in percent; phagocytic activity. Coefficients of ratio 
monocytes to lymphocytes – M/Lf and neutrophils, monocytes to lymphocytes (N+M)/Lf were 
calculated. To determine number of neutrophils, the blood, which was obtained from a cubital vein, 
stabilized with heparin (final concentration 10 U/ml) and diluted with Hanks solution in a ratio 1:1. 
It was used a double gradient for the selection of immunocompetent cells: ficoll ("Pharmacia", 
Sweden) – verografin ("Spopha", Czech Republic) with a density 1.077 g/cm3 and 1.115 g/cm3 
respectively. In the centrifuge tubes were sequentially layered on 2.5 ml of a gradient component 
and 4 ml of diluted blood. There were received three layers of cells after centrifugation: an upper 
layer – macrophages and lymphocytes, middle – granulocytes and lower – erythrocytes. Neutrophils 
were taken with Pasteur pipette, washing twice in buffered physiological saline solution (pH-7.4). 
After washing, neutrophils were weighed in Hanks solution 5х105 cells/ml. All manipulations were 
performed in the silicone dishes. Relative number of T–lymphocytes (phenotype CD2+, СD3+) and 
B–lymphocytes (phenotype СD22+) was conducted by immunofluorescence method with 
monoclonal antibodies. Coefficient of ratio T–and B–lymphocytes (T/B) was determined. We 
concerned lymphocytes without markers of B– and T–cells to the null cells.  
Results of Research and their Discussion  
Patients with mandible fracture and abscess of a bone wound, have leukocytosis at the 
hospitalization. Coefficient (N+M)/Lf was shown activity of inflammatory reactions in the given 
group of patients. It was increased on 22.7%, compare with indicators in control group (table 1).  
Table 1. Content and coefficient of leukocytes’ ratio in the blood of patients (М±m) 
Indicators/Ratios Groups 
Control 
 (n=20) 
Basic (n=25) 
before treatment on 7 day of 
treatment 
on 14 day of 
treatment 
Leukocytes 
(х109/l) 
6.52±0.61 9.22± 0.13* 7.62±0.21 6.63±0.41** 
Neutrophils 
 (%) 
58.51±2.63 62.35±2.51* 
 
60.83±1.62**  
 
58.52±2.01 
Monocytes 
 (%) 
6.40±0.52 5.61±0.64 7.23±0.42** 
 
6.42±0.53 
Lymphocytes 
 (%) 
28.91±0.20 25.83±2.10 30.20±1.61* 29.40±1.71 
Lf/M 
(s.u.) 
4.53±0.12 4.63±0.12 4.33±0.11 4.83±0.12 
(N+M)/Lf 
(s.u.) 
2.20±0.11 2.75±0.11 2.32±0.12 2.20±0.14 
Note: * – p < 0.05 in comparison with healthy persons; ** – p < 0.05 compare with indicators 
in the basic group before treatment.  
 
According to the results of our research was shown severe inflammatory process in the 
patients from basic group before treatment.  
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On the other hand, on this stage of observation was shown the reduction of phagocytic index 
on 40.3%, and phagocytic number on 47.7% (table 2), compared with indicators in the control 
group. 
Table 2. Subpopulation of lymphocytes and phagocytic activity in dynamics in both groups of 
patients (M±m) 
Indicators Groups 
Control 
 (n=20) 
Basic (n=25) 
before treatment on 14 day of 
treatment 
T–lymphocytes 
 (CD2+ , CD3+) 
(%) 
54.51±2.12 30.62±2.41* 
 
29.43±1.72* 
B–lymphocytes 
 (CD22+) 
(%) 
14.52±2.61 13.42±1.85 11.56±1.12 
Null cells 
 (%) 
32.73±0.62 57.83±1.64* 
 
60.23±1.72* 
Т/В 
(s.u.) 
3.93±0.64 2.34±0.32 3.20±0.11 
Phagocytic 
activity 
Phagocytic index 
(%) 
54.83±1.61 32.71±1.80* 44.24±1.65** 
Phagocytic number 
(s.u.) 
6.52±0.14 3.41±0.10* 5.64±0.93** 
Note: * – p < 0.05 in comparison with healthy persons; ** – p < 0.05 compare with indicators 
in the basic group before treatment.  
Indicators of cellular immunity in the basic group of patients were decreased. Firstly, content 
of CD2+ and CD3+ cells decreased on 43.9%, compared with indicators in the control group. As the 
result, ratio T– and B–lymphocytes reduced on 41.0%. Content of null cells increased on 76.8 %. 
On the 7th day of postoperative treatment in the basic group of patients level of leukocytes 
decreased on 16.5% (p < 0.05), but monocytes increased on 28.6% (p<0.05). Number of 
lymphocytes increased on 13.4% (p < 0.05), in comparison with initial indicators. It was indicated 
about reduction of an inflammatory and active current of the reparative processes.  
After 14 day of clinical observations, amount of leukocytes and ratio of (N+M)/Lf were 
decreased to the normal value. The given process described degree of inflammation. On this stage 
of treatment, in the basic group of patients were noted signs of the cellular immunity recovery. The 
phagocytic index was significantly increased on 35.2% and phagocytic number – on 64.7%, in 
comparison with initial level. However, amount of T–lymphocytes and null cells was significantly 
different from indicators in the control group. 
Discussion 
Suppuration of a bone wound at the mandible fracture was observed after 3-7 days of injury. 
Hematoma infection was situated between the bones’ ends. A poor body resistance in patient 
carried out to the infection of the fracture gap. However, this process did not involve inflammation 
separate parts of a bone tissue and necrosis of the bone beams. They were located in a big distance 
from the fracture gap and could lead to the formation of sequester.  
Standard treatment of the inflammatory disease (opening of an abscess, antimicrobial therapy, 
infusion therapy, enhancement of nonspecific resistance an organism, etc.) carried out to the 
decreasing symptoms of inflammation process. Consolidation of the bone fragments carried out in 
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the standard terms. This clinical situation is commonly regarded as the festering wounds of a bone, 
which finished with a rejection of the primarily necrotic tissue and its regeneration [12]. 
Indicators of cellular immunity are objectively characterized a body condition in children and 
adults with pathology of different systems. It is well-known, that immune system's response to the 
inflammation should be focused on the changes of  lymphocytes number and phagocytic activity. 
It is known that all types of the immune system cells were growth from precursors in a bone 
marrow.  Important place takes lymphocyte memory. Firstly, it covered T–lymphocytes, which 
transfer from a bone marrow and should arrive to another central organ of the immune system – 
thymus. At the same time, various additional factors occur during immune responses. All of them 
are affecting on a bone metabolism [13]. Secondary, active forms of T–cells characterized by the 
formation of interleukin-6, inflammatory cytokine and osteoclastogenesis stimulator. T–cells also 
directly stimulate formation of osteoclasts on such way, which is not dependent from 
osteoclastogenic cytokine– receptor activator of the nuclear factor kappa-beta (RANK), and its 
ligand (RANKL) [14]. Signal RANKL/RANK regulated formation of the multinucleated osteoclasts 
from their precursors. Primary, it promotes their activation and survival under condition of standard 
bone remodeling and at the various pathological conditions. Osteoprotegerin ligand (OPG) protects 
a skeleton from excessive bone resorption by binding with RANKL, preventing binding with its 
receptor RANK. Thus, ratio RANKL/OPG is an important determinant of bone mass and integrity 
of the skeleton [15]. 
OPG regulates the lymph node organogenesis, lymphocyte development and interactions 
between T –cells and dendrites cells in the immune system. Both systemic and local activation of 
T–cells can lead to the production of OPG and subsequent bone loss. Generally, T–cells are 
regulators of a bone physiology [16]. Bone resorption is initiated by leukocytes, activated in the 
peripheral blood stream [17]. 
Osteoclast-activating factor (OAF) is a strong stimulator of the osteoclastic bone resorption 
[18]. OAF should be secreted by mononuclear cells in a peripheral blood stream, when exposed by 
a specific antigen. Both the lymphocytes and monocytes initiated release of OAF. Results of our 
research was shown that: (a) activated lymphocyte included the cells or OAF source,                      
(b) prostaglandins produced by monocytes, were necessary for OAF production by the activated 
lymphocytes, and (c) prostaglandins of monocytes have an indirect effect on the bone resorption, 
regulating OAF production, and activation of osteoclasts. Interaction of OAF and prostaglandins in 
the places of bone resorption has an important role at the inflammatory diseases, associated with 
bone destruction [19]. 
Decreasing of T–lymphocytes, increasing of null lymphocytes, on a background of increased 
leukocytes in a peripheral blood stream in patients with mandible fracture could indicate about 
suppression of numerous factors, leading to the formation of osteoclasts and affects the bone 
resorption. 
Phagocytic activity of neutrophils usually increased at the early development of inflammatory 
process. Its reduction leads to the chronic inflammation and autoimmune process beginning. As the 
result of this, destruction function and circulating immune complexes elimination from the body 
takes place.  
Any inflammatory process carried out throughout complete process of decreasing                
T–lymphocytes. High sensitivity of T–lymphocytes level in the blood should caused by the 
following activity. The most active T–lymphocytes with granulocytes quickly transfer to the centre 
of inflammation. T–cells with a poor metabolic activity (young, old or defective cells and cells with 
blocked receptors, i.e. temporarily inactive) should stay in a bloodstream. They are poorly identified 
by the routine laboratory methods. That’s why they should concern to the category of null cells.  
However, some authors considered that increased formation of null cells supports a variety 
of T–lymphocytes spectrum after regression. Primary, increasing formation of the immature 
lymphocytes is the reaction of compensation of Т– cells deficiency. Production of T– null cells is 
decreases. Cellular and humoral immunity depends on the T–lymphocytes number, was suddenly 
decreasing [20].   
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Patients with mandible fractures, which complicated with suppuration of a bone wound, 
have the immune deficiency (reduction number of lymphocytes and monocytes; phagocytosis 
activity, T–lymphocytes) of the functional origin. This process is observed as the result of influence 
numerous exogenous and endogenous adverse factors. At the same time, decreased of     
T–lymphocytes and monocytes was shown as protective reaction of the body, carried out to the 
further damage of a bone, which caused by activation of osteoclastogenesis. Generally, a bone 
resorption is initiated by activation of leukocytes in peripheral blood stream. Intensive formation of 
immature lymphocytes is protective reaction of a body, which focused on the suppression of 
inflammatory processes. After surgical intervention, on a background of leukocytes reduction, was 
shown high amount of lymphocytes and monocytes and increasing of phagocytic activity. Content 
of null cells was increased on a background of decreasing proportion of T–lymphocytes.  
Conclusions 
Patients with mandible fracture, complicated with abscess of a bone wound, have decreased 
indices of the cellular immunity: phagocytic index – on 40.3%, phagocytic number – on 47.7%, 
content of CD2+ and CD3+lymphocytes – on 43.9%, on a background of leukocytosis. Content of 
null cells was increased on 76.8 %.  
On the 7th day of postoperative treatment in the basic group of patients’ level of leukocytes 
decreased on 16.5%, monocytes increased on 28.6%, lymphocytes increased – on 13.4%. It is 
indicated about reduction of the inflammatory process and about active current of reparative 
process. After 14 day of clinical observation, leukocytes and lymphocytes returned to the standard 
values. It was noted increasing of the phagocytic activity, but quantity of T– lymphocytes was 
reduced. Content of null cells had not significant differences from initial level before treatment. 
Indicators of cellular immunity demonstrated incompleteness of an inflammatory process and 
immunosuppression in two weeks after traditional treatment of suppuration in a bone wound, in a 
case of mandible fracture. All these findings required primary implementation of a new approach to 
the pathogenetic therapy of the given diseases.  
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